Literature DB >> 31714339

Blood pressure dipping and sleep quality in the Wisconsin Sleep Cohort.

Beini Lyu1, Erika W Hagen, Laurel A Ravelo, Paul E Peppard.   

Abstract

AIMS: Nondipping blood pressure (BP) is associated with higher risk for hypertension and advanced target organ damage. Insomnia is the most common sleep complaint in the general population. We sought to investigate the association between sleep quality and insomnia and BP nondipping cross-sectionally and longitudinally in a large, community-based sample.
METHODS: A subset of the Wisconsin Sleep Cohort (n = 502 for cross-sectional analysis and n = 260 for longitudinal analysis) were enrolled in the analysis. Polysomnography measures were used to evaluate sleep quality. Insomnia symptoms were obtained by questionnaire. BP was measured by 24-h ambulatory BP monitoring. Logistic regression models estimated cross-sectional associations of sleep quality and insomnia with BP nondipping. Poisson regression models estimated longitudinal associations between sleep quality and incident nondipping over a mean 7.4 years of follow-up. Systolic and diastolic nondipping were examined separately.
RESULTS: In cross-sectional analyses, difficulty falling asleep, longer waking after sleep onset, shorter and longer total sleep time, lower sleep efficiency and lower rapid eye movement stage sleep were associated with higher risk of SBP and DBP nondipping. In longitudinal analyses, the adjusted relative risks (95% confidence interval) of incident systolic nondipping were 2.1 (1.3-3.5) for 1-h longer waking after sleep onset, 2.1 (1.1-5.1) for 7-8 h total sleep time, and 3.7 (1.3-10.7) for at least 8-h total sleep time (compared with total sleep time 6-7 h), and 1.9 (1.1-3.4) for sleep efficiency less than 0.8, respectively.
CONCLUSION: Clinical features of insomnia and poor sleep quality are associated with nondipping BP. Our findings suggested nondipping might be one possible mechanism by which poor sleep quality was associated with worse cardiovascular outcomes.

Entities:  

Mesh:

Year:  2020        PMID: 31714339      PMCID: PMC7882242          DOI: 10.1097/HJH.0000000000002283

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  40 in total

1.  Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study.

Authors:  Takayoshi Ohkubo; Atsushi Hozawa; Junko Yamaguchi; Masahiro Kikuya; Kaori Ohmori; Mari Michimata; Mitsunobu Matsubara; Junichiro Hashimoto; Haruhisa Hoshi; Tsutomu Araki; Ichiro Tsuji; Hiroshi Satoh; Shigeru Hisamichi; Yutaka Imai
Journal:  J Hypertens       Date:  2002-11       Impact factor: 4.844

2.  A prospective study of sleep duration and coronary heart disease in women.

Authors:  Najib T Ayas; David P White; JoAnn E Manson; Meir J Stampfer; Frank E Speizer; Atul Malhotra; Frank B Hu
Journal:  Arch Intern Med       Date:  2003-01-27

Review 3.  Night-time blood pressure patterns and target organ damage: a review.

Authors:  Faye S Routledge; Judith A McFetridge-Durdle; C R Dean
Journal:  Can J Cardiol       Date:  2007-02       Impact factor: 5.223

Review 4.  Insomnia and Risk of Cardiovascular Disease.

Authors:  Sogol Javaheri; Susan Redline
Journal:  Chest       Date:  2017-01-30       Impact factor: 9.410

Review 5.  Assessment and management of blood-pressure variability.

Authors:  Gianfranco Parati; Juan E Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

6.  Poor sleep quality, stress status, and sympathetic nervous system activation in nondipping hypertension.

Authors:  Yuli Huang; Weiyi Mai; Yunzhao Hu; Yanxian Wu; Yuanbin Song; Ruofeng Qiu; Yugang Dong; Jian Kuang
Journal:  Blood Press Monit       Date:  2011-06       Impact factor: 1.444

Review 7.  Sleep, insomnia, and hypertension: current findings and future directions.

Authors:  S Justin Thomas; David Calhoun
Journal:  J Am Soc Hypertens       Date:  2016-12-29

8.  Sleep disturbance is associated with cardiovascular and metabolic disorders.

Authors:  Michael A Grandner; Nicholas J Jackson; Victoria M Pak; Philip R Gehrman
Journal:  J Sleep Res       Date:  2011-12-12       Impact factor: 3.981

9.  Nocturia, nocturnal activity, and nondipping.

Authors:  Rajiv Agarwal; Robert P Light; Jennifer E Bills; Lindsey A Hummel
Journal:  Hypertension       Date:  2009-07-06       Impact factor: 10.190

10.  Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk.

Authors:  Paola A Lanfranchi; Marie-Hélène Pennestri; Lorraine Fradette; Marie Dumont; Charles M Morin; Jacques Montplaisir
Journal:  Sleep       Date:  2009-06       Impact factor: 5.849

View more
  5 in total

Review 1.  Sympathetic neural responses to sleep disorders and insufficiencies.

Authors:  Ian M Greenlund; Jason R Carter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-01-07       Impact factor: 4.733

2.  Influence of postural changes on nasal resistance in patients with obstructive sleep apnea.

Authors:  Yunhan Shi; Hongfei Lou; Huijun Wang; Yi Zhou; Li Wang; Yanru Li; Demin Han
Journal:  Sleep Breath       Date:  2022-08-03       Impact factor: 2.655

3.  Insomnia and cardiovascular outcomes.

Authors:  Monica L Andersen; Dalva Poyares; Sergio Tufik
Journal:  Sleep Sci       Date:  2021 Jan-Mar

Review 4.  Insomnia and circadian misalignment: an underexplored interaction towards cardiometabolic risk.

Authors:  Barbara Nobre; Isabel Rocha; Charles M Morin; Miguel Meira E Cruz
Journal:  Sleep Sci       Date:  2021 Jan-Mar

5.  Association of Sleep Characteristics With Nocturnal Hypertension and Nondipping Blood Pressure in the CARDIA Study.

Authors:  S Justin Thomas; John N Booth; Byron C Jaeger; Demetria Hubbard; Swati Sakhuja; Marwah Abdalla; Donald M Lloyd-Jones; Daniel J Buysse; Core E Lewis; James M Shikany; Joseph E Schwartz; Daichi Shimbo; David Calhoun; Paul Muntner; Mercedes R Carnethon
Journal:  J Am Heart Assoc       Date:  2020-03-19       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.